Resources

Selected
  • Systematic reviews (SYSVAC)
Type of publications
Regions
Diseases
Vaccine topics
Target population
Publication date

3152 results found

2023 ∙ Bachour, Y.

An update and overview of the literature on late inflammatory reactions (LIRs) in soft tissue fillers after SARS-CoV-2 infection and vaccination

  • All age groups
  • COVID-19
  • Safety
Methodological quality (AMSTAR 2):
Critically low
2023 ∙ Thammathiwat, T. Banjongjit, A. Iampenkhae, K. Townamchai, N. Kanjanabuch, T.

ANCA Associated Glomerulonephritis Following SARS-CoV-2 Vaccination: A Case Series and Systematic Review

  • Adults
  • Older adults
  • COVID-19
  • Safety
Methodological quality (AMSTAR 2):
Critically low
2023 ∙ Dimitroglou, Margarita Sokou, Rozeta Iacovidou, Nicoletta Pouliakis, Abraham Kafalidis, Georgios Boutsikou, Theodora Iliodromiti, Zoi

Anti-SARS-CoV-2 Immunoglobulins in Human Milk after Coronavirus Disease or Vaccination-Time Frame and Duration of Detection in Human Milk and Factors That Affect Their Titers: A Systematic Review

  • Pregnant women
  • COVID-19
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Critically low
2023 ∙ Dimitroglou, M. Sokou, R. Iacovidou, N. Pouliakis, A. Kafalidis, G. Boutsikou, T. Iliodromiti, Z.

Anti-SARS-CoV-2 Immunoglobulins in Human Milk after Coronavirus Disease or Vaccination—Time Frame and Duration of Detection in Human Milk and Factors That Affect Their Titers: A Systematic Review

  • All age groups
  • Pregnant women
  • COVID-19
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Critically low
2023 ∙ Roslan, M. Nisfu, F. R. M. Arzmi, M. H. Wahab, R. A. Zainuddin, N.

Antibody Response against Severe Acute Respiratory Syndrome Coronavirus 2 Messenger Ribonucleic Acid Vaccines in Infected Individuals: A Systematic Review

  • Healthcare workers
  • COVID-19
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Critically low
2023 ∙ Domado, A. M. Adaza, H. J. F. Beltran, Apnc Buenviaje, L. M. Co, C. D. Combalicer, L. R. Corona, S. M. A. Cruz, J. B. F. Dinjotian, Macg Esperanzate, E. M. S. Luna, S. R. G. Pascua, E. J. R. Vicencio, R. R. T. Reyes, S. N.

Antibody titers of individuals vaccinated for COVID-19: A systematic review

  • Adults
  • Older adults
  • COVID-19
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Critically low
2023 ∙ Scheffer, M. M. J. Coffeng, L. E. O'Mahony, J. F.

Appropriateness of strategy comparisons in cost-effectiveness analyses of infant pneumococcal vaccination: A systematic review

  • Newborn
  • Pneumococcal disease
  • Economic aspects
Methodological quality (AMSTAR 2):
Not applicable
2023 ∙ Fleszar-Pavlovic, Sara E. Cameron, Linda D.

Are Interventions Efficacious at Increasing Human Papillomavirus Vaccinations Among Adults? A Meta-Analysis

  • Adults
  • Human papillomavirus (HPV)
  • Acceptance
  • Coverage
Methodological quality (AMSTAR 2):
Not applicable
2023 ∙ de Bruin, O. Phijffer, E. Ahmadizar, F. van der Maas, N. Wildenbeest, J. Sturkenboom, M. Bont, L. Bloemenkamp, K.

Are maternal vaccines effective and safe for mothers and infants? A systematic review and meta-analysis of randomised controlled trials

  • Pregnant women
  • Efficacy/effectiveness
  • Safety
Methodological quality (AMSTAR 2):
Low
2023 ∙ Hoang, T. N. A. Quach, H. L. Hoang, V. N. Tran, V. T. Pham, Q. T. Vogt, F.

Assessing the robustness of COVID-19 vaccine efficacy trials: systematic review and meta-analysis, January 2023

  • All age groups
  • COVID-19
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Critically low
Loading...